Source:http://linkedlifedata.com/resource/pubmed/id/14978932
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2004-2-24
|
pubmed:abstractText |
In Ph(+) CML patients who achieved complete cytogenetic response (CCR) with interferon-alpha (IFN) treatment, how long the treatment should be continued has not well been investigated. We report here 2 CML cases who stopped the treatment after CCR had been sustained with IFN for 2-3 years. A 49-year-old male (case 1) achieved CCR 6 months after the initiation of IFN treatment. CCR had been maintained for 3 years, and then the treatment was ceased. CCR has been sustained without any therapy for 4 years. In this case, RT-PCR became negative half a year after achievement of CCR, and since then negative RT-PCR has been maintained. In case 2, a 50-year-old male, CCR was achieved after 8 years of IFN treatment, and maintained for 2 years. One month after cessation of the treatment, CML relapsed cytogenetically. In case 2, negative RT-PCR results were not maintained during the period of CCR. In case 1, the levels of T-cells for PR 1 were undetectable in the peripheral blood.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0485-1439
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1161-5
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14978932-Antineoplastic Agents,
pubmed-meshheading:14978932-Cytogenetic Analysis,
pubmed-meshheading:14978932-Drug Administration Schedule,
pubmed-meshheading:14978932-Humans,
pubmed-meshheading:14978932-Interferon-alpha,
pubmed-meshheading:14978932-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:14978932-Male,
pubmed-meshheading:14978932-Middle Aged,
pubmed-meshheading:14978932-Neoplasm Recurrence, Local,
pubmed-meshheading:14978932-Remission Induction,
pubmed-meshheading:14978932-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:14978932-Time Factors,
pubmed-meshheading:14978932-Treatment Outcome
|
pubmed:year |
2003
|
pubmed:articleTitle |
[Chronic myelogenous leukemia in cessation of therapy after sustained CCR with interferon].
|
pubmed:affiliation |
Division of Hematology, NTT Kanto Medical Center.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|